Ara
Toplam kayıt 26, listelenen: 21-26
Evaluation of Iron Overload in the Heart and Liver Tissue by Magnetic Resonance Imaging and its Relation to Serum Ferritin and Hepcidin Concentrations in Patients with Thalassemia Syndromes
(Springer India, 2017)
Iron overload is one of the major prognostic factor in thallassemia patients. We aimed to evaluate iron accumulation in the heart and liver by MRI in thalassemia major, thalassemia intermedia, and S- thalassemia patients ...
The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans
(De Gruyter Open Ltd, 2017)
Objective: Dermatofibroma (DF) is a benign fibrohistiocytic tumor whereas dermatofibrosarcoma protuberans (DFSP) has intermediate malignant potential. CD34 is the most commonly used antibody in differentiating these tumors. ...
Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome
(Soc Brasileira Dermatologia, 2017)
Deferasirox is an iron chelator agent used in the treatment of diseases with iron overload, such as thalassemia and myelodysplastic syndrome. Although the majority of adverse reactions of deferasirox involve gastrointestinal ...
Pustular eruption induced by etanercept in a patient with ankylosing spondylitis: a rare side effect
(Kare Publ, 2015)
Etanercept is a tumor necrosis factor alpha (TNF-alpha) antagonist with anti-inflammatory effects. It is used in the treatment of dermatologic and rheumatologic diseases such as rheumatoid arthritis, polyarticular juvenile ...
Primer malignant giant cell tumour of kidney: a case report
(The Royal College of Surgeons of England, 2021)
Osteoclast-like giant cell tumours of the kidney are extremely rare and usually accompanied by a conventional urothelial neoplasm such as papillary, transitional renal cell, or sarcomatoid carcinoma. Although they have ...
Survival outcomes of hypomethylating agents maintenance therapy in new diagnosed AML patients: Real experience data
(PMC, 2022)
Objective: Acute myeloid leukemia (AML) is a hematological malignancy that frequently affects elderly population. With introducing the hypomethylating agents (HMAs) in elderly AML treatment, survival rates and quality of ...